The Industry That is Depending on Science and Regulation to Grow

Yuran Li, Director, MS Commercial Strategies, Alternative Biomedical Solutions (ABS), is a biochemist by training. Still, his fascinations with physics, math, and probability have led him down some interesting paths, including some stints in the professional poker world. Lucky for ABS, he chose the science route.

Cannabis is a schedule 1 drug classification by the U.S. Federal government. As more and more states legalize it, there is a growing need for reliable testing to ensure the safety and potency of cannabis products. ABS is one of the pioneers in cannabis method development and testing. Li spoke with Jason Claybrook on some of ABS’s activities surrounding Cannabis.

Any product that people consume goes through testing to ensure their safety. “Cannabis is unique in that it’s ultimately a weed,” Li said. And it can prove quite a challenge to cultivate because the plant can soak up a lot of pesticides and other elements used for pest control. “Additionally, the Cannabis plant itself also uptakes quite a lot of heavy metals, things like arsenic and lead.” Accumulation of these pollutants can harm humans, so accurate testing is essential.

Some of the testing ABS does on Cannabis is to look for micro toxins, like mold and soil pollutants. And from a marketing and regulatory standpoint, they test for potency. In some cases, testing can help ensure that a strain grown for CBD does not contain THC. One challenge Li cautioned is every state has different guidelines, and it is essential to understand the laws governing each state where Cannabis sales are allowed.

Another aspect of lab testing that is becoming more and more important for Cannabis is label testing. As with craft beers and whiskey, labels need to back up their product’s claims. Testing ensures the strain offered on the label is the strain received by the consumer.

More Stories Like This:

Breaking through ‘Pilot Purgatory’ in Innovating New Solutions

Is Cryptocurrency and Its Tech Infrastructure Ready for a Revolution?

Follow us on social media for the latest updates in B2B!

Image

Latest

design
Where Design Meets Durability: Why Commercial Surfaces Must Support Safety, Cleanability, and Long-Term Value
June 8, 2026

When a commercial space fails, it often fails quietly: a lobby floor that becomes slippery when wet, a hotel bathroom that is difficult to clean, a healthcare surface that cannot withstand constant disinfection, or an office finish that looks great until afternoon glare makes the room uncomfortable. These are not purely aesthetic problems; they are…

Read More
creative career
Crafted Journey How To: Building a Creative Career Across Scripts, Stages, and Sound
June 8, 2026

Creative careers rarely move in a straight line, especially for writers working across stage, screen, audio, books, and independent film. Sustaining that kind of life often means finding opportunities wherever they appear, building a strong network, staying open to different formats, and saying yes to collaborations that can lead somewhere unexpected. The stakes are…

Read More
EMR
EMR Strategy, Consulting, and Career Pivots with MedSys Co-Founder Mark Embry
June 8, 2026

Electronic medical records (EMRs) have moved from a back-office upgrade to a frontline determinant of care quality, clinician burnout, and hospital economics. With U.S. hospitals often spending tens to hundreds of millions—sometimes exceeding $100 million—on EMR implementations, the stakes have never been higher for getting both the technology and the human adoption right. As…

Read More
radiology
Growing Without Compromise: How Vision Radiology Balances Scale, AI, and Clinical Quality
June 4, 2026

Radiology sits at the center of a modern healthcare squeeze: imaging volumes are climbing, hospitals need faster reads, and there simply are not enough radiologists to meet demand the old way. At the same time, remote work and AI are reshaping what a clinical practice can look like. The challenge is no longer whether…

Read More